These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

209 related articles for article (PubMed ID: 6448605)

  • 21. Treatment of Paget's bone disease with the bisphosphonate APD.
    Mautalen CA
    Henry Ford Hosp Med J; 1983; 31(4):244-8. PubMed ID: 6425243
    [No Abstract]   [Full Text] [Related]  

  • 22. [Effects of the combined calcitonin and sodium etidronate therapy in Paget's disease of bone].
    Nuti R; Turchetti V; Righi G; Vattimo A
    Minerva Med; 1982 Mar; 73(9):467-72. PubMed ID: 6801555
    [TBL] [Abstract][Full Text] [Related]  

  • 23. 'Breaking the back' of Paget's bone disease.
    Ryan WG
    Arch Intern Med; 1989 Dec; 149(12):2639. PubMed ID: 2531996
    [No Abstract]   [Full Text] [Related]  

  • 24. Paget's disease of bone.
    Nagant de Deuxchaisnes C; Rombouts-Lindemans C; Huaux JP; Devogelaer JP; Malghem J; Maldague B; Withofs H; Meersseman F
    Br Med J (Clin Res Ed); 1982 Jan; 284(6311):274. PubMed ID: 6799139
    [No Abstract]   [Full Text] [Related]  

  • 25. Treating Paget's disease.
    Anderson DC; Cantrill JA
    Br Med J (Clin Res Ed); 1987 Jun; 294(6585):1486. PubMed ID: 3111600
    [No Abstract]   [Full Text] [Related]  

  • 26. The cardiovascular system in Paget's disease of bone and the response to therapy with calcitonin and diphosphonate.
    Henley JW; Croxson RS; Ibbertson HK
    Aust N Z J Med; 1979 Aug; 9(4):390-7. PubMed ID: 292378
    [No Abstract]   [Full Text] [Related]  

  • 27. Paget's bone disease treated with diphosphonate and calcitonin.
    Hosking DJ; Bijvoet OL; van Aken J; Will EJ
    Lancet; 1976 Mar; 1(7960):615-7. PubMed ID: 55896
    [TBL] [Abstract][Full Text] [Related]  

  • 28. [Combined treatment of Paget's disease of bone with calcitonin and the diphosphonate EHDP].
    Jaeger P; Bischoff-Delaloye A; Burckhardt P
    Schweiz Med Wochenschr; 1981 Dec; 111(49):1893-7. PubMed ID: 6800028
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Treatment of Paget's disease of bone.
    Singer FR
    Postgrad Med; 1975 Mar; 57(3):117-20. PubMed ID: 123333
    [No Abstract]   [Full Text] [Related]  

  • 30. Clinical and biological effects of low doses of (3 amino-1 hydroxypropylidene)-1,1-bisphosphonate (APD) in Paget's disease of bone.
    Heynen G; Delwaide P; Bijvoet OL; Franchimont P
    Eur J Clin Invest; 1982 Feb; 12(1):29-35. PubMed ID: 6802650
    [No Abstract]   [Full Text] [Related]  

  • 31. Biochemical and clinical responses to dichloromethylene diphosphonate (Cl2MDP) in Paget's disease of bone.
    Douglas DL; Duckworth T; Kanis JA; Preston C; Beard DJ; Smith TW; Underwood I; Woodhead JS; Russell RG
    Arthritis Rheum; 1980 Oct; 23(10):1185-92. PubMed ID: 6448604
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Treatment of Paget's disease of bone (osteitis deformans) with sodium etidronate (EHDP).
    Rashid M; Khairi A; Johnston C
    Clin Orthop Relat Res; 1977; (127):94-105. PubMed ID: 410576
    [No Abstract]   [Full Text] [Related]  

  • 33. Improvement in the deformity of the face in Paget's disease treated with diphosphonates.
    Bickerstaff DR; Douglas DL; Burke PH; O'Doherty DP; Kanis JA
    J Bone Joint Surg Br; 1990 Jan; 72(1):132-6. PubMed ID: 2137127
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Letter: Diphosphonate and calcitonin in Paget's disease.
    Hosking DJ; Bijvoet OL
    Lancet; 1976 May; 1(7966):970. PubMed ID: 57380
    [No Abstract]   [Full Text] [Related]  

  • 35. [Pharmacological treatment of osteitis deformans (Paget's bone disease)].
    Brixen KT; Abrahamsen B; Kassem MS; Mosekilde L
    Ugeskr Laeger; 2005 Feb; 167(9):1009-12. PubMed ID: 15803994
    [No Abstract]   [Full Text] [Related]  

  • 36. Pamidronate sodium and calcitonin-resistant Paget's disease. Immediate response in a patient.
    Drake S; Massie JD; Postlethwaite AE; Palmieri GM
    Arch Intern Med; 1989 Feb; 149(2):401-3. PubMed ID: 2783843
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Duration of effect of oral diphosphonate therapy in Paget's disease of bone.
    Gray RE; Yates AJ; Preston CJ; Smith R; Russell RG; Kanis JA
    Q J Med; 1987 Sep; 64(245):755-67. PubMed ID: 2966965
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Diphosphonates for otospongiosis.
    Stutzmann JJ; Petrovic AG
    Am J Otol; 1985 Jan; 6(1):89-95. PubMed ID: 3156507
    [No Abstract]   [Full Text] [Related]  

  • 39. Effects of disodium dichloromethylene diphosphonate on Paget's disease of bone.
    Meunier PJ; Chapuy MC; Alexandre C; Bressot C; Edouard C; Vignon C; Mathieu L; Trechsel U
    Lancet; 1979 Sep; 2(8141):489-92. PubMed ID: 90215
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Paget's disease: state of the art.
    Avioli LV
    Clin Ther; 1987; 9(6):567-76. PubMed ID: 2964271
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 11.